H-Index
17
Scimago Lab
powered by Scopus
eISSN: 1941-5923
call: +1.631.629.4328
Mon-Fri 10 am - 2 pm EST

Logo

MSMbanner
Medical Science Monitor Basic Research

Annals
ISI-Home

Isoflavones and menopause

Krzysztof Pałgan

CaseRepClinPractRev 2001; 2(4):283-289

ID: 475349

Available online:

Published:


In woman the risk of the atherosclerosis, particularly coronary heart disease and stroke, osteoporosis increases after the onset of menopause. There is evidence from large studies that a continuaus substitution with estrogen could dramatically decrease the risk of cardiovascular disease and osteoporosis. Many women are reluctant to take estrogenic drugs because of side effects, such as resumption of menstrual bleeding, breast tenderness, and weight gain.

Keywords: Isoflavones, Genistein, daidzein, Menopause, coronary heart disease, Osteoporosis, breast cancer, hrt



Back